IP
IndiaPulse

HONASA

Large Cap

Honasa Consumer Limited

Consumer

Honasa Consumer Limited is an Indian beauty and personal care company. It operates a portfolio of brands including Mamaearth and The Derma Co., focusing on 'inside-out beauty' with a digital-first approach and expanding offline distribution.

₹407.95
-6.95 · -1.68%
Quote09 Jun, 10:02 am
Fundamentals08 Jun 2026 · screener
Score08 Jun, 11:00 pm · v4.2-nightly
Tags02 May 2026
Data confidence
Fresh enough for analysis
Investor decision lenses

One read, four checks

75+ is strong, 60-74 is usable, 45-59 is mixed, and below 45 needs caution. These are research lenses, not buy/sell instructions.

Mixed fundamentals, management trust is supportive, price trend is neutral, and recent execution is consistent.

Suggested next step
Research, do not rush
The four lenses are not strongly aligned. Compare peers and wait for a cleaner setup.
U-Score
FAIR VALUE
46

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Trust
Healthy Trust
78

low confidence · 0/0 claims checked

Technical
Neutral
54

Timing lens: price trend and sector relative strength.

Result consistency
stable
77

Rolling lens: recent quarterly delivery, not the latest single-result score.

Latest result

Quarter ended 31 Mar 2026

Excellent · 100/100

Rev +23% YoY · PAT +176% YoY · margin expansion · +9% QoQ · operating leverage

Filed 21 May 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹657 Cr+23.0%+9.1%
EBITDA₹77 Cr+185.2%+18.5%
Operating margin12.0%+700 bps+100 bps
PAT₹69 Cr+176.0%+38.0%
PAT margin10.5%+582 bps+219 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Business and thesis

Where growth can come from, and what can break the case

Thesis intactReviewed 2026-06-03T17:42:18.396Z
Management commentary snapshot

Q4 FY26 revenue grew 28% YoY (LFL) to INR 682 Cr, with EBITDA scaling 2.5x+ to INR 77 Cr (11.3% margin). FY26 revenue grew 20% YoY (LFL) to INR 2,479 Cr, and EBITDA tripled to INR 231 Cr (9.3% margin), demonstrating profitable growth.

Honasa delivered strong Q4 and FY26 results, driven by volume growth and margin expansion. Focus categories and younger brands show robust traction. The maiden dividend payout signals confidence. Sustaining market share gains and offline expansion are key for continued performance.

Growth engines

Focus Category Strategy

Focus Categories grew at 35%+ in Q4 FY26 and 29%+ YoY in FY26. Their contribution expanded by 500 bps YoY to 80%+ in Q4 FY26.

Younger Brands Momentum

Younger brands (The Derma Co., Aqualogica, Dr. Sheth’s, BBlunt Staze, Reginald Men) grew at 40%+ in Q4 FY26, continuing strong growth.

Offline Distribution Expansion

~120K outlets billed directly through distributors in FY26 and 10,000+ Modern Trade outlets reached, strengthening offline demand capture.

Hero Products Scaling

Mamaearth Rice Face wash, Rosemary Shampoo, 1% Hyaluronic Sunscreen Aqua Gel, Sali-Cinamide Facewash heroes are crossing meaningful ARR milestones.

Tailwinds

Rising Role of Nutraceuticals

The next frontier of I-Beauty, moving from niche to mainstream, with ~40% growth in searches for Hair Care and Skin Care Nutraceuticals from FY24 to FY26.

Influencer & Dermatologist Effect

Rising health influencers and dermatologists on digital platforms are driving mainstream consumer adoption of nutraceuticals.

Beauty from Inside Trend

Increasing consumer attribution to factors that address the root cause to solve beauty concerns, fueling demand for inside-out solutions.

Management accountability

What management said, and what results must prove

Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.

Analyst reading lens
Compare YOY

The presentation primarily compares Q4 FY26 with Q4 FY25 and FY26 with FY25, indicating a focus on annual performance and growth trends over seasonal fluctuations.

Sector KPIs management disclosed

Underlying Volume Growth (UVG)

30% in Q4 FY26 and 23% in FY26, indicating volume-led growth.

Gross Profit Margin

71.4% in Q4 FY26 (+69 bps YoY improvement) and 71.2% in FY26 (+83 bps YoY improvement).

EBITDA Margin

11.3% in Q4 FY26 (185%+ YoY growth) and 9.3% in FY26 (237%+ YoY improvement).

PAT Margin

10.2% in Q4 FY26 (175%+ YoY growth) and 8.1% in FY26 (175%+ YoY growth).

Management forward view

Shareholder Rewards Commitment

The Board recommended a maiden dividend distribution of INR 3 per share, representing 51.2% of FY26 Standalone PAT, subject to shareholder approval.

Investment in Talent

The company is hiring talent to build new businesses and expand the leadership team, including specialists in digital-first brands.

CSR Initiatives

Honasa has planted 1,101,200+ trees to date, with a target of 2,000,000+ by 2030, and supports education and health checkups.

Thesis monitor

Numbers and claims to verify in the next filings

CheckpointCurrent evidenceWhat to verify next
Underlying Volume Growth30% (Q4 FY26), 23% (FY26)Monitor sustained volume-led growth across categories and brands.
Gross Profit Margin71.4% (Q4 FY26), 71.2% (FY26)Watch for continued margin expansion amidst input cost trends and competitive pricing.
Offline Channel Penetration~120K direct billed outlets, 10K+ MT outletsTrack further penetration and sales contribution from General Trade and Modern Trade channels.
Younger Brands Performance40%+ growth in Q4 FY26Assess continued strong growth momentum and profitability of newer brands like The Derma Co. and Aqualogica.

Verification checkpoints are IndiaPulse research interpretation, not investment advice.

Technical timing lens

Trend score and candlestick chart

54Neutral

SMA20 +32.4% / mo · near 52W high

Stock trend: 60
Sector RS: 45
Sector 3M: -0.7% vs Nifty +0.1%

Technical chart

HONASAweekly · 1Y+32.9%
Latest close ₹407.95 on 2026-06-09
Bar
-0.5%
RSI
69
MACD hist
1.58
52W pos
90%
Hover for OHLC, volume, and indicators. Use range buttons above the chart to zoom.
₹240₹288₹337₹385₹43452H52L2025-062025-092025-122026-03Vol2025-062025-102026-012026-052026-06
Up bar
Down bar
Volume
Result date
SMA 50
RSI(14)

Technical trend read

Mixed signals

Signals are conflicting — long-term trend unclear. RSI 69. Wait for confirmation.

  • SMA20 rising (~24.5% over last month) — short-term momentum positive.
  • RSI(14) at 69 — falling, no extreme reading.
  • MACD above signal but histogram contracting — bullish momentum cooling.
  • 4% off 52W high · 64% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Deep research

Valuation, score drivers, trust methodology, financials, and peers

Use these sections after reviewing the decision summary, latest result, thesis, management accountability, and technical timing above.

46U-SCORE
Financial Turnaround

Fundamental score breakdown

FAIR VALUE
Valuation5/30
Growth14/25
Quality12/20
Balance Sheet9/15
Cash Flow2/10
Piotroski
8/9 (+5)
Penalties
-1
Raw sum
46

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

46/100 · FAIR VALUE

Positive drivers

  • Piotroski is strong at 8/9.
  • Fair-value margin of safety is positive at 15.0%.
  • Quality contributes 12/20 to the score.

Main drags

  • Penalty bucket subtracts 1 points.
  • Valuation is weaker at 5/30; verify the latest quarterly trend.
  • Cash flow is weaker at 2/10; verify the latest quarterly trend.
Sector valuation model

Consumer valuation: PE/PEG and brand-quality premium

Consumer franchises can deserve higher multiples, but only when growth quality supports them.

Consumer PE/PEG
Primary lens
PE and PEG relative to growth, ROE, margins, and brand strength.
Secondary checks
Volume growth, pricing power, distribution, same-store or category growth.
Main risk check
Premium valuation needs durable growth and margin resilience.
PE
66.3
PB
9.6
EV/EBITDA
48.7
ROE
15.7%
ROCE
19.2%
FCF Yield
0.9%
Debt/Equity
0.1
MoS
+15.0%
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 08 Jun 2026
v4.2-nightly
Final score
46
Previous: 46
Verdict
FAIR VALUE
Previous: FAIR VALUE
Margin of safety
+15.0%
Previous: +13.7%

Score history

12 stored score snapshots. Latest stored move: +0 points.

08 Jun 2026
v4.2-nightly
47
46
46
46
46
46
46
46
46
46
46
46

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.
Trust Score
78Healthy Trust · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Healthy Trust: Claim history is still being built. It ranks around the 87th percentile of the scored universe and 87th percentile within Consumer. No major sub-score weakness stands out.

High Trust Lite: Promoter pledge is zero. Key concern: OPM spread across recent quarters is 19%.

Computed 08 Jun 2026
management-trust-v1
54 docs indexed · 28 concall links
Score band
Healthy Trust

Generally investable credibility. Look for weak sub-scores before increasing position size.

Relative rank
87th percentile

overall median 67 · Consumer: 87th pctile, median 67 · Large: 68th pctile, median 74

Evidence depth
Financial-only

54 documents indexed, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Healthy Trust · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Can support position sizing if valuation and trend also agree.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
65
acceptable · profit to cash conversion
Balance sheet
96
strong · leverage and solvency
Discipline
76
strong · capital discipline
Results
77
strong · quarterly consistency

Trust positives

  • Promoter pledge is zero.
  • FCF yield is positive at 0.9%.
  • Debt/equity is 0.10.
  • 4/4 latest quarters had positive YoY revenue growth.

Trust risks

  • OPM spread across recent quarters is 19%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Intrinsic value

Graham Number
₹77.49
-426.4% MoS
DCF Fair PE
78.0
DCF Fair Value
₹479.7
+15.0% MoS
PEG
2.44

Fundamentals

Valuation

P/E
66.30
P/B
9.56
EV/EBITDA
48.70
Market Cap
13500.00Cr

Profitability

ROE
15.70%
ROCE
19.20%
ROA
11.06%
Dividend Y

Growth (CAGR)

Revenue 5Y
39.00%
EPS 5Y
17.00%
Revenue 3Y
17.00%
EPS 3Y
42.50%

Balance Sheet

Debt/Equity
0.10
Interest Coverage
18.15×
Altman Z
8.88
Book Value
43.40

Cash Flow

FCF Yield
0.92%
FCF Positive Y
2/5
OCF
141.00 Cr
EPS TTM
6.15

Shareholding

Promoter Hold
35.54%
Promoter Pledge
0.00%
Momentum 52W
94%

Financial History

Updated 9/6/2026

Revenue

₹ Cr
No data

Net Profit

₹ Cr
No data

Return on Equity

%
No data
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.